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Background: Our randomized controlled trial (The BETTER Trial) found that training a clinician to become a Prevention
Practitioner (PP) in family practices improved chronic disease prevention and screening (CDPS). PPs were trained on
CDPS and provided prevention prescriptions tailored to participating patients. For this embedded qualitative study, we
explored perceptions of this new role to understand the PP intervention.
Methods: We used grounded theory methodology and purposefully sampled participants involved in any capacity
with the BETTER Trial. Two physicians and one coordinator in each of two cities (Toronto, Ontario and Edmonton,
Alberta) conducted eight individual semi-structured interviews and seven focus groups. We used an interview guide
and documented research activities through an audit trail, journals, field notes and memos. We analyzed the data using
the constant comparative method throughout open coding followed by theoretical coding.
Results: A framework and process involving external and internal practice facilitation using the new role of PP
was thought to impact CDPS. The PP facilitated CDPS through on-going relationships with patients and practice
team members. Key components included: 1) approaching CDPS in a comprehensive manner, 2) an individualized
and personalized approach at multiple levels, 3) integrated continuity that included linking the patients and practices
to CPDS resources, and 4) adaptability to different practices and settings.
Conclusions: The BETTER framework and key components are described as impacting CDPS through a process that
involved a new role, the PP. The introduction of a novel role of a clinician within the primary care practice with skills
in CDPS could appropriately address gaps in prevention and screening.
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Chronic conditions affect at least one third of Canadians
with their prevalence increasing steadily [1,2]. They have
a substantial impact on the use of healthcare services
[1]. Family practice is an ideal setting for most chronic
disease prevention and screening (CDPS) actions and* Correspondence: dmanca@med.ualberta.ca
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available to improve CDPS, but they are inconsistently
applied [3-17]. Examples include the use of electronic
medical records (EMR), reminder systems [11], evidence-
based guidelines and tools for CDPS actions, patient
targeted interventions such as self-management tools
[8-10,12,13], and practice-based quality improvement
strategies such as practice facilitators [4,6,7,14-16,18].
The Building on Existing Tools to Improve Chronic
Disease Prevention and Screening in Family Practice
(BETTER) Trial is one example of a successful approach
for CDPS that built on existing evidence and applied itLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Trial was to determine whether CDPS for diabetes, cancer
(colon, cervical and breast), heart disease and their associ-
ated lifestyle risk factors could be improved in the family
practice setting using: 1) a practice-level intervention,
and/or 2) a Prevention Practitioner (PP) intervention
through a prevention visit with a specially trained exist-
ing member of the family practice team, the Prevention
Practitioner (PP) [19]. The primary outcomes included
patient screening activity and health behavior change as
measured by the Summary Quality Index (SQUID), a
composite index of CDPS [20], and adherence at follow-
up (~7 months) after the prevention visit. Full details
of the BETTER Trial are published elsewhere [19]. We
report here the qualitative strand conducted to understand
the contextual factors associated with the positive effect
of the PP role within the Better Trial.
The PPs were interdisciplinary health care providers
within the family practices and included: registered nurses,
a licensed practical nurse, nurse practitioners, and a
registered dietitian. Patients aged 40–65 years were
invited to participate in the structured PP intervention
by completing a health survey and then attending a
visit with the PP. Through a rigorous evidence-review
process, evidence based clinical guidelines were identified
for inclusion in the BETTER CDPS tool kit [21]. The PP
was trained in CDPS including: appropriate prevention
and screening actions, practice and patient resources to be
used during patient encounters, additional CDPS patient
resources within and outside the practice, motivational
interviewing and shared decision making.
The PP reviewed the patients’ health surveys and medical
records to identify preventive actions that patients were
eligible to receive. At the time of the visit, through a
process of shared decision making and motivational
interviewing, a written personalized prescription with
prevention and screening goals was tailored to the patient.
A significant improvement in the SQUID outcome was
observed 7 months later in the PP intervention group
[19], demonstrating the effectiveness of this approach.
This qualitative study was conducted with the objective
of better understanding the PP intervention in the BET-
TER Trial described above, including the development
of the PP role, perceived barriers, facilitators, benefits
and disadvantages, and of exploring the feasibility and
sustainability of this approach for CDPS.
Methods
The BETTER Trial involved four family practice settings
in Edmonton, Alberta and four in Toronto, Ontario. It
was a mixed methods project that included a pragmatic
cluster randomized controlled trial [19] with a qualitative
strand. Since our aim for the qualitative strand was to
develop an understanding of the PP intervention, thistype of question was best suited to a grounded theory
(sociology) approach [22-24]. Therefore, an embedded
mixed-methods design [25] was used to understand the
PP intervention and to inform the future dissemination
and implementation of the approach used in the BET-
TER Trial.
Participants
To minimize biasing participants, interviews were con-
ducted before the dissemination of the positive results to
the participants. For the qualitative strand, we sought
perceptions from the PP’s, participating clinicians and
administrators. Individuals were eligible to participate from
all of the BETTER sites or if they were involved in the
BETTER Trial in any capacity. Purposeful sampling was
used to recruit participants including PPs, study personnel,
clinic support personnel, organizational administrators,
intervention and control physicians, other clinic physicians
not involved in the project, and clinicians who worked in
the clinic. Physicians were selected based on the following
characteristics: gender, years in practice, community or
academic setting, type of EMR used, physicians with and
without patients participating in the BETTER Trial. Poten-
tial participants received a detailed letter of information de-
scribing the project and inviting them to participate. Both
the interviews and focus groups were conducted in person
at which time we obtained written informed consent.
The qualitative study, including the recruitment and
consent process, received ethics approval from the Univer-
sity of Alberta (Health Research Ethics Board Pro00026547)
and the University of Toronto (Health Science Research
Ethics Board # 27125) in December 2011. The Trial
registration number of the original BETTER RCT was
ISRCTN07170460.
Data collection
Data collection involved individual semi-structured inter-
views and focus groups (FG) conducted by two BETTER
Trial physician investigators and one research coordinator
in each city (Edmonton and Toronto). Semi-structured
interviews were offered to key informants, physicians
or policy personnel when a more candid response was
sought. The family physician researchers had expertise
in qualitative research (DM, AC, MG, JC) and the research
coordinators were non-clinicians (CA, LP). A physician
attended each interview since physician participants may
be more candid in their response when an interviewer
is a fellow physician [26]. A minimum of one physician
and one coordinator attended each interview to provide
a clinical and a non-clinical perspective. With minimum
of two researchers attending the interviews, one was able
to focus on leading and maintaining the discussion, while
the other focused on recording notes and observations.
An audit trail was kept for the entire study and consisted
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activities including interviews, discussions and decisions.
Each investigator also captured three types of data:
1) Field notes taken immediately after each interview/FG
described general observations such as how people
were positioned and non-verbal communication, ideas
on possible linkages, potential biases, areas requiring
further exploration, reflections on the interview guide,
thoughts on sampling and who to approach for
further clarification of information.
2) Journals documented a personal audit trail that
included evolving perceptions, understandings,
potential biases and contrary information that
needed further exploration.
3) Memos are fundamental to grounded theory [22,27]
and were written throughout the research process.
Memos included thoughts on developing ideas,
relationships between ideas, and evolving theory.
An interview guide was tested on non-study participants
to ensure all areas were captured. The interviews were
audio recorded and transcribed. The interviews explored
the BETTER PP intervention including perceptions on
feasibility and sustainability of the model for CDPS. Two
main guiding questions elicited the participants’ stories
followed by open ended questions and focused prompts
when needed (Additional file 1: Interview guide):
Analysis
The analysis was conducted using techniques informed
by grounded theory methods including the constant
comparison method, [22,27,28] which also involved seek-
ing outliers and alternative explanations. The interviews
were transcribed verbatim and initially read through and
audio-reviewed. Transcripts were then coded line by line
with each idea given a name or phrase summarizing the
main concept by each investigator independently. The
investigators involved in the analysis and coding included
six family physicians (DM, AC, GS, MG, JC, JP) and two
non-clinicians (CA, LP) (four in Alberta and four in
Ontario). This initial coding was reviewed at a face-to-
face team meeting to develop some consensus on the
codes. The codes were then grouped according to their
properties and types into categories and overarching
themes. Relationships between different ideas began to
emerge and were written as memos. Initially the memos
were brief descriptions and early conceptualizations.
Through the sorting and resorting of the memos into
different groupings and constantly comparing how each
memo was related to another [22] the researchers devel-
oped a better understanding of the relationships between
different concepts and categories, giving the categories di-
mension and position within the evolving understandingof the situation [28]. Through this evolving understanding
the memos become more extensive as they integrated
the ideas from earlier memos generating higher-level
memos that moved from a descriptive to a conceptual
understanding of the evolving framework [22,27].
Each investigator independently drafted journals, and
memos of their understandings and themes. These were
posted on a secure website and shared with the team.
The lead investigator (DM) collected and sorted the
information and then posted the collated ideas, themes
and categories on the website for review and comments
from the team. As the researchers became immersed in
coding, a better understanding was developed and this
was reflected in higher-level memos [22,27]. At this point
a teleconference was held with the research team to
develop consensus on evolving themes and hypotheses
and future directions to take when re-reviewing the
transcripts to capture higher-level memos and conduct
selective coding.
The codes were managed manually during the initial
open coding and thematic development phase. With a
rough understanding of concepts and themes N-Vivo 10
software was then used by DM to further review and
capture the evolving understanding and selective coding.
The second round of memos were collected and sorted
and a framework was developed. A second teleconference
was held with the research team to review and refine the
evolving framework. The analysis and interpretation was
further refined and validated through triangulation with
two key informants (PPs).
Rigor of study methods
Several methods were used to ensure the credibility and
consistency or transferability of our findings [23,29-32].
Primarily, grounded theory is best suited to address our
objective of developing an understanding of a process
[22-24,31]. Researcher reflexivity is also an important
component [29,30] and to reduce bias, clinicians and
non-clinicians were involved in the interviews and in the
analysis. The research team met and questioned each
other’s findings and preconceptions and looked to the
data for further explanations.
We sought a diverse sample to identify and describe
common patterns that transcend a focused sample, provid-
ing themes that were common to all [31,33]. Theoretical
sampling was used to identify participants from the poten-
tial informants since a constant comparative method was
used to guide future interviews, that is, we sought data that
would challenge and support our evolving understanding,
seeking exceptions and looking for variation [27,33].
The research team communicated through face-to-face
meetings, emails and through documents posted on a
secure website. The use of an interview guide ensured
completeness, reduced systematic variance, and assisted
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comparative method [34]. The interviewers’ field notes
collected observations not captured in audio recordings,
ensuring comprehensiveness as a form of triangulation,
whereby data is gathered from more than one source
[24,29,30]. Triangulation was also achieved through
theoretical sampling whereby differing perspectives were
sought [27,30]. Coding the interviews independently and
then meeting regularly to review and compare themes and
concepts generated improved rigor and credibility. An
audit trail was created throughout the data collection
and analysis stages to help with the constant comparison
of the data. The information generated met Glaser’s
four criteria for judging grounded theory, including
fit, relevance, workability and modifiability [27]. Fur-
thermore, respondent validation, or “member checking”,
helped to ensure that the interpretations were accurate
[24,29,30].
Interviews were conducted until saturation was achieved
to ensure that the data categories were dense and the
relationship between categories were well established
and validated and that no new or relevant data was
being obtained; and that all our avenues and leads had
been followed and the description was complete [27].
Results
A total of 45 individuals participated in Alberta and
Ontario, including five men and 40 women (refer to
Table 1). Individual interviews were held with eight key
informants, four in Ontario and four in Alberta. These
individuals included administrators, family physicians,
and a PP. A total of seven focus groups were conducted
at the primary care sites participating in the project,
four in Edmonton and three in Toronto. These focus
groups included PPs, study personnel, clinic support
personnel, organizational administrators, intervention
and control physicians, other clinic physicians not
involved in the project, and clinicians who worked in
the clinic.
Participants highlighted that CDPS is not seen as a pri-
ority, nor is it integrated or remunerated in the present
health care system. The BETTER Trial introduced a CDPS
intervention into the practices (see Figure 1). The BET-
TER Trial was viewed as providing a framework for CDPS
in a primary care system that often focuses on acute and
chronic disease management rather than prevention. The
results in this paper will focus on the theoretical frame-
work that emerged as a possible solution to addressing
CDPS in primary care.
“The project brings a framework and an opportunity to
spend time because we wouldn’t otherwise engage a
patient in that process, it’s not remunerated you know”.
(Physician)The BETTER framework
Categories, themes and memos that emerged from the
data were sorted and organized into a framework. The
BETTER framework included (refer to Figure 2):
1) A newly developed role of PP with expertise in CDPS.
2) A unique combination of external and internal
practice facilitation.
3) Key components, described below, that contribute
to the success of CDPS (refer to Figure 3).
A novel role – the prevention practitioner (PP)
Participants viewed prevention and screening as an activity
shared by many health care providers in the primary
care setting. However it may not be well coordinated
and no one has a comprehensive skill set in this area.
Figure 1 The BETTER chronic disease prevention and screening prevention practitioner intervention.
Figure 2 The BETTER chronic disease prevention and screening framework.
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Figure 3 Key components of the BETTER approach.
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their day-to-day practice.
“I guess the interesting thing is like to call yourself a
primary Prevention Practitioner it’s not a protected
term under like the regulated health professional
block right and so it’s a, and like primary prevention
falls within the scope of multiple professionals”.
(Pharmacist)
The PP was specifically trained to fulfill this new role
and introduce the defined BETTER CDPS intervention
into the practices (see Figure 1). Participants viewed this
added skill set positively.
“… the BETTER project because it you know had the
educational component, and it had a lot of, it really
helped us define your role, and a lot of you know
what you do in a patient encounter, and what you
do even when I’ve identified oh this patient has
hyperlipidemia, can you please see them to have the
discussion, you kind of inadvertently have this nice
framework”. (Physician)External and internal practice facilitation
Practice facilitation has been described as a supportive
service provided to primary care practices by a trained
individual or team of individuals [35] and practice facili-
tators are specially trained individuals who work with
primary care practices to make meaningful changes to
improve patients’ outcomes [35]. A facilitator can be inter-
nal or external to a practice [35]. The BETTER Trial
increased CDPS in the practice and the patients through a
combination of external and internal practice facilitation.
External facilitation
Originally we conceptualized the PP intervention of the
BETTER Trial as only an internal practice facilitation
intervention. However, it became apparent during the
interviews and focus groups that the BETTER research
trial itself provided external facilitation support to the
intervention. The external facilitation included facilitating
the introduction of the intervention at the sites and the
training and supporting of the PP role.
Physician leads were identified at each site to facilitate
the introduction of the PP to that site.
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with great enthusiasm and asked if we would support
it …” (Administrator)
Training and ongoing project support helped the PPs
define and expand their new roles within the practice,
and to develop the required skills to fulfill their new
role. Regular teleconferences provided opportunities
to share ideas and support one another in managing
specific clinical situations.
“a big part of the training was we did a lot of
teleconference calls amongst the BETTER project team
and all of the PPs so as we were starting into the
project, as questions came up, it gave us all a chance
to discuss how we were treating certain situations and
you know exactly, the steps we were supposed to take
so, that certainly evolved as we went along too”. (PP)
External facilitation was more important at the begin-
ning of the intervention to help develop the skills for
PPs to fulfill their new role, and to assist the practices in
adapting to the new PP role. Modifications were made
as needed to ensure a good fit within each practice.
Internal facilitation
The PP facilitated change within the practice through
the introduction of skills, tools and resources for CDPS.
“So it enhanced what we were doing. I mean helped
even some of the guidelines she came up with, it was
part of her tool kit”. (Physician)
The PP transformed the practice to incorporate CDPS
into daily practice activities. This enabled the practice
to better support the patient in their individual CDPS
goals. Change was accomplished through the PPs’ unique
positions in the practices and their ability to develop rela-
tionships with the patients, the clinical teams and the
physicians. The PPs developed relationships with patients
that were distinct and unique from the doctor-patient
relationship and, in some cases, patients disclosed infor-
mation to the PP that they would not disclose in a group
setting or even to their own physician.
“The only thing with the group things though is people
may not share their own personal blocks like reasons
they are not doing it in a group the same way they
would share things with the PP one on one and
sometimes the PP might be listening to things that the
patients are uncomfortable telling us about”. (Physician)
“The PP uncovered a lot more alcohol use”. (Physician)The PPs developed relationships with other members
of their primary care teams that engaged the practice in
CDPS at both a practice and a patient-level.
“And so that enhanced ongoing care and, and the
patients related to her as part of the team and then
she was able to do the follow-ups and she could
key me in on which patients had been through
BETTER or she’d leave a note on the EMR to say
you know this is some of things to discuss at the
next appointment so that prompted me to address
certain things that maybe the patient was already
aware of and enhance that uptake for the patient”.
(Physician)
The PPs generated internal facilitation through the rela-
tionships with their team. This was crucial to sustaining
the intervention and, once established, the PP role contin-
ued to incorporate CDPS in some of the practices, in
some form, even after the BETTER Trial was completed.
“But even so it, we saw them in the office after the
BETTER Project and there’s that relationship built there
and they do, we do, I do still bring it up if I recognize
them from the BETTER Project I do pull up those goals
that are scanned into their chart, we still do go over it
because it’s just an ongoing support for them right”. (PP)
The role of the PP combined with external and internal
practice facilitation provided a framework for CPDS that
transformed the practice through the use of relationships
with someone internal to the practice as illustrated in
Figure 2.
Key components
Key components that contributed to the success of the
BETTER Trial were identified including (see Figure 3):
1. A comprehensive, pro-active, and holistic approach
to CDPS that broadened the PP’s scope of practice.
“I think as holistic front end screen is really
important. I think it’s also a real big way to support
inter-professional team practice because you can, you
have the opportunity to look holistically at a patient in
terms of what their needs might be and in terms of the
kinds of services that you might offer”.
(Organization manager)
“Well I just think as a model it’s you know, for a
complimentary, collaborative team practice around
stepping up roles, allowing people to work to scope or
expanding scope and that was …an example of
expanding scope in someone whose area of work is
nutrition”. (Physician)
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multiple levels tailored to the practice and the
patient. The study fostered important relationships
between the PP, patient, and practice as a whole,
including physicians and other team members. For
example, personal invitations sent to the patient
from their physician helped to start a dialogue about
CDPS and the support they could receive from their
primary care team.
“I mean we all had the protocol, we all had, you know
the policies we had to do, but everybody did it their
own way”. (PP)
“ It’s patient engagement and then you’re building a
relationship and then it’s, I firmly believe that you get
your best outcomes if, if you can achieve a positive
outcome in patient care around prevention if you have
trust and it has to be a personal relationship”.
(Physician)
3. Integrated continuity involved as a process of
longitudinal continuity of information and personal
relationships that integrated CDPS into the practice.
The PP identified CDPS resources (e.g. dieticians for
dietary advice), and when necessary, referred
patients to resources within and outside the practice
setting and where necessary referred patients to
those resources. Other clinicians in the practice
became better acquainted with those resources and
began integrating them into their clinical activities.
This improved utilization of internal and external
CDPS resources. The PP followed-up with the
patients’ goals and communicated plans with the
entire team. When the patient saw other clinicians
in the practice those clinicians were also aware of
the patients’ CDPS goals and could provide further
support to them to achieve their goals.
“… we had this great opportunity as part of BETTER
to have one of our team members you know get this
training and expertise you need training and I guess
the issues of what do we do about it now and how you
know because it is a shared competency like how do
we create a system where we aren’t doing piecemeal
patient care but all team members feel optimized and,
and as if their skills are being used as well”. (Pharmacist)
4. Adaptable through a collaborative approach at the
PP, practice, and patient-level.
“I think it creates a stronger collaboration, it, it’s a
better team connection in that the role becomes well
defined, and very important. I suppose one that can becustomized to different practices, people work in
different ways and she’s, happens to be very flexible so,
yeah it led to some strong collaboration that way”.
(Physician)
Discussion
It has been estimated that it would take an additional
7.4 hours a day for a physician to address the US pre-
ventive services task force recommendations [36]. Our
qualitative analysis also highlights a perceived lack of
health care system support for CDPS in the family practice
setting. It is clear that we need to approach CDPS in a
different way. The BETTER Trial addressed this CDPS
gap through a novel approach, building capacity in an
existing member of the primary care team to have a new
role as Prevention Practitioner with expertise in CDPS.
The BETTER Trial, informed by Ontario’s chronic dis-
ease framework [17], developed an integrated approach
to CDPS that aimed to address different facets of the
framework including health care organizations, practice
teams and individuals and families. A clinical working
group selected and harmonized the high-quality recom-
mendations for the chronic conditions in the BETTER
Trial [21]. The BETTER pragmatic cluster randomized
controlled trial demonstrated that a unique intervention
through a PP could improve the implementation of clin-
ically important CDPS in a cost-effective manner [19].
This effective intervention directly focused on the patient
through the use of a PP who met with the patient and
through a process of shared decision making and mo-
tivational interviewing developed a prescription tailored
to the patient.
Primary care requires expertise and roles that are differ-
ent from the traditional biomedical model. For example,
new roles such as patient navigators [37-39] have been
developed to address gaps in chronic disease management.
These new roles may have an impact on outcomes and
effectiveness [39-41], and could reduce health dispar-
ities [41-44]. It is important to address CDPS in socially
disadvantaged populations since the prevalence of chronic
disease is higher than the general population [2,45]. The
PP role may be able to address the CDPS gap through
reduction of risk factors, and through a proactive
approach, target the needs of vulnerable populations.
There is evidence that modest changes in risk factor
levels can bring about large improvements in health
and thus reduce this burden of care [1].
The PP intervention had several key components. One
was comprehensiveness, that is, the focus was on evidence
based CDPS actions in patients 40–65 years of age, and
not on a specific disease or condition. Focusing on the
common modifiable risk factors of multiple chronic
conditions is clearly more cost effective and compre-
hensiveness is important in enhancing equity in health
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equity can be improved through person-focused pre-
vention and improved coordination [46]. Both of these
were key components of the BETTER Trial. We describe
a new approach to integrated continuity that resulted in
improved integration of CDPS into the practice. This
was made possible through the continuity of the PP’s
relationships with the patient, the physician and other
members of the practice, and making links between
internal and external CPDS resources and activities.
This was how coordination was improved and how other
clinicians in the practice became engaged in facilitating
patients’ CDPS goals.
Further work is needed to determine if the BETTER
approach can be adapted to other settings and should
include patient perspectives. The main limitation of this
project was that the practices involved in the project
were located in urban centers and used EMRs. They
could be seen as early adopters compared to those not
using an EMR, and may tend to serve patients with a
higher socioeconomic status as compared to practices in
other locations such as inner city or rural. Hence the
findings may not be transferable to those settings.
Conclusions
The BETTER Trial Prevention Practitioner (PP) interven-
tion impacts CDPS through a framework that involves
external and internal practice facilitation using a novel
role, the PP. The key components include: 1) approaching
CDPS in a comprehensive and proactive manner, 2) an
individualized and personalized approach at multiple levels,
3) integrated continuity of CPDS for the patient and within
the practice, and 4) adaptability. The introduction of a
novel role within the primary care practice with skills
and expertise in CDPS may address gaps in prevention
and screening.
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